Why Publication Practice Counsel?

Publication Practice Counsel is your trusted partner with experienced professionals to help you ensure ethical publication practices and compliance within your organization. With over 20 years of experience in scientific communications and publication ethics & compliance, we are the publication specialist that pharmaceutical, biotech, and medical device companies; clinical and academic research organizations; and academic researchers can rely on.

Your TRUSTED partner for PUBLICATION EXCELLENCE

Blog:

It's here...ICMJE Requirements on Data Sharing!

Published on June 6, 2017. Read more>

[New Book Release] Recoding Scientific Publishing: Raising the Bar in an Era of Transformation

Published on January 28, 2017. Read more>

Strategies to Improve Compliance with Disclosure and Publication of Clinical Trial Results

Published on November 7, 2016. R ead more>

Integrated Approach to Planning for Publication & Data Sharing

Published on September 26, 2016. Read more>

Testimonials

“…by far the best Publication professional I have ever worked with. Relationship with KOLs and investigators is phenomenal and has the ability to get articles written and published in very high quality journals. Astutely commercially oriented and assist in the development of marketing and sales messages and programs.”

M. Lambertson, BioPharmaceutical Executive

“…incredibly knowledgeable on all matters related to Pharma supported clinical trial publications. Can provide guidance and clear actionable steps on issues such as authorship, disclosures, Sunshine and EFPIA reporting of TOV, metrics, audit readiness. Instrumental in developing and implementing corporate SOPs, guidance's and Publications policy. Knowledge and advice are a great asset to anyone looking to improve or update their publications approach.”

S. Owen, Head of Global Scientific Communications, Novartis Oncology

“…collaborative and knowledgeable professional. Very good technical understanding of our products/clinical data and worked with the clinical team to ensure high quality publications. Always provided sound guidance on how to manage sensitive authorship issues with our external collaborators and has a good understanding of all of the regulations and guidelines pertaining to publications and scientific disclosures.”

K. McKerracher, VP, Global Program Head, Novartis Oncology